Apellis Pharmaceuticals
APLS
#3776
Rank
HK$26.63 B
Marketcap
HK$210.48
Share price
2.84%
Change (1 day)
-18.01%
Change (1 year)

Market capitalization of Apellis Pharmaceuticals (APLS)

Market cap: HK$26.63 Billion

As of January 2026 Apellis Pharmaceuticals has a market cap of HK$26.63 Billion. This makes Apellis Pharmaceuticals the world's 3776th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Apellis Pharmaceuticals from 2017 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$26.63 B8.34%
2025HK$24.58 B-22.11%
2024HK$31.55 B-43.03%
2023HK$55.39 B24.01%
2022HK$44.67 B24.47%
2021HK$35.89 B6.88%
2020HK$33.58 B120.26%
2019HK$15.24 B162.3%
2018HK$5.81 B-31.88%
2017HK$8.53 B

End of Day market cap according to different sources

On Jan 8th, 2026 the market cap of Apellis Pharmaceuticals was reported to be:

HK$25.89 Billion
by Nasdaq info icon info icon
HK$25.89 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
HK$6.81 B-74.40%๐Ÿ‡บ๐Ÿ‡ธ USA